scholarly journals Ultrasound Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 Expression for Endometrial Receptivity Evaluation

Theranostics ◽  
2015 ◽  
Vol 5 (2) ◽  
pp. 206-217 ◽  
Author(s):  
Hongmei Liu ◽  
Yihan Chen ◽  
Fei Yan ◽  
Xiaohua Han ◽  
Junru Wu ◽  
...  
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Molecular Imaging ◽  
Growth Factor ◽  
Growth Factor Receptor ◽  
Endometrial Receptivity ◽  
Vascular Endothelial ◽  
Ultrasound Molecular Imaging ◽  
Endothelial Growth Factor

Fortgeschrittenes medulläres Schilddrüsenkarzinom: Vandetanib verbessert das progressionsfreie Überleben

2012 ◽  
Vol 03 (02) ◽  
pp. 93-92
Author(s):  
Alexander Kretzschmar
Keyword(s):  
Vascular Endothelial Growth Factor ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Growth Factor Receptor ◽  
Phase Iii ◽  
Vascular Endothelial ◽  
Medulläres Schilddrüsenkarzinom ◽  
Epidermal Growth ◽  
Endothelial Growth Factor

Vandetanib ist ein oraler Hemmer des RET-Kinase-, VEGF (Vascular Endothelial Growth Factor Receptor)- und EGFR (Epidermal Growth Factor Receptor)-Signalwegs. In einer zulassungsrelevanten, randomisierten, doppelblinden, placebokontrollierten Phase- III-Studie verlängerte der Tyrosinkinasehemmer das progressionsfreie Überleben (PFS) signifikant länger als Placebo.

Sign in / Sign up

Export Citation Format

Share Document